Severe COVID-19 infection linked to overactive immune cells
Samples from the lungs of patients show a runaway immune system reaction could be one mechanism behind severe COVID-19 cases
Samples from the lungs of patients show a runaway immune system reaction could be one mechanism behind severe COVID-19 cases
Fluidigm COVID-19 campus safeguard program improves availability of non-invasive, saliva-based SARS-CoV-2 tests for higher education institutions
Join us on Monday, October 19, to find out how targeting BCMA and GPRC5D simultaneously could help to prevent tumor cell escape
Harvey J. Alter, Michael Houghton, and Charles M. Rice are joint winners of 2020 Nobel Prize for medicine
Researchers have made a significant COVID-19 drug target discovery using Thermo Fisher Scientific CryoEM technology
We speak with Dr. Ed Emmott, founder of The Emmott Lab & COVID-19 Mass Spec Coalition member, about his latest research into the disease
Affimer-based research assay launched alongside performance data published by Bruker
Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions in the field
Explore our roundup of key considerations for a successful CRISPR/Cas9 experiment
Early surgical treatment of leg ulcers caused by varicose veins improves healing and reduces the risk of the condition coming back
CE mark for MitraClip G4 offers physicians an innovative next-generation system with more options for mitral valve repair using proven clip-based technology
Menu of test solutions for infectious diseases – which already includes COVID-19 – to be expanded, especially in the U.S.
Promega and Incyte intend to work together in the future to develop the Promega OncoMate MSI Assay as a companion diagnostic
The Direct assay is validated on a wide range of specimen types, and can be run in parallel with the Simplexa Flu A/B & RSV Direct Gen II assay